title: An open response to the technology scoping report examining the clinical and cost effectiveness of silver.
authors.affiliation: Professor of Tissue Viability, University of Worcester, UK.
authors.forename: R
authors.initials: R
authors.lastname: White
mesh_terms: D000287:Administration, Topical; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001458:Bandages; D003362:Cost-Benefit Analysis; D006801:Humans; D018030:Silver Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects; D014946:Wound Infection / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000890:Anti-Infective Agents; D018030:Silver Compounds